Advanced Machine Learning and Artificial Intelligence for Drug Discovery and Development

28th - 29th May 2019 in London, United Kingdom

Add to Calendar

WHY ATTEND

Identifying Key Tools- Next Step Towards Effective Drug Discovery and Development

speakers

interactive sessions

days networking

participants

Hurry Up! Only seats left

Register Now

About the Forum

This exclusive forum showcases ways how to use AI and machine learninig in drug discovery and developing. Global Pharmaceutical Industry leaders will meet to exchange their experience and share knowledge throughout 2-day in-depth panel discussions, practical case studies, interactive sessions and workshops and the small-scale nature of the event and carefully picked panel of senior executives, experts and business professionals will ensure them with great benchmarking, networking and business opportunities.

Learn more
logo

Expected Participants according to Postitions

Expected Participants according to Industries

Some of Our Past Speakers

Cambridge Consultants
We specialise in helping our clients achieve the seemingly impossible.

From large multinationals to innovative start-ups, our clients trust us to solve their most critical, high-risk challenges. Through our combination of exceptional people, proven processes and world-class facilities, we deliver lasting impact.
ROCHE
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
GlaxoSmithKline
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
NOVARTIS
We believe Novartis is well prepared for a world with a growing, aging population and continuously evolving healthcare needs. We have a clear mission, focused strategy and strong culture, all of which we expect will support the creation of value over the long term for our company, our shareholders and society.
Imperial College London
TEVA
Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days. We do this by developing, producing and marketing affordable, high quality generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.
previous arrow
next arrow
Shadow
Slider

Past Schedule Excerpt

08:00

Registration and Morning Coffee

08:30

Business Card Exchange

09:00

Chairman’s Opening Remarks

Jaquie Finn / Head of Digital Health / Cambridge Consultants
09:10

Unlocking the Potential of Machine Learning for Drug Discovery & Development

Case Study

Roche
09:40

Indication Expansion & Drug Positioning – Opportunities for Translational Sciences

Case Study

Bayer AG
10:10

Are Pharma Companies Ready to Adopt these Technologies and Revolutionize Healthcare?

Panel Discussion

10:40

Morning Coffee and Networking

11:10

From Finance to AI Drug Discovery: Implementation of the Modern Portfolio Theory (MPT) on Drug Pipelines

Case Study

Pepticom
11:40

How are Leaders Using Big Data Analytics to Achieve Better, Faster Customer Decisions?

Keynote Case Study

Genomics England
12:10

Use of Advanced Analytics in Target Selection and Validation

Case Study

GSK R&D
12:40

Enhancing Customer-Centricity using AI/ Machine Learning

Keynote Case Study

14:30 - 19:00

All sessions inFULL AGENDA

08:30

Chairman’s Opening Address

9:00 - 13:00

All sessions inFULL AGENDA

13:00

Lunch Time + Coffee and Networking Break

14:20

Cyber Threats- How Immune is the Pharma Industry?

Case Study

KPMG
14:50

Reality of Today or Dream of Tomorrow? Leveraging Big Data to Transform Pharma Industry

Case Study

15:10

Afternoon Coffee and Networking

15:40

Blockchain: Advantages in Pharma Supply Chain

Case Study

Cambridge Consultants
16:10

Chairman’s Closing Remarks and End of Conference

Case Study

MEDIA PARTNERS

logologologologologo

About Pharmaphorum

We are a content and communications company offering a unique hybrid combination of publishing heritage and journalism and the creativity and expertise of an agency. pharmaphorum.com is a leading destination for news and information for pharma professionals, serving 300k of them every month as a Google-recognised source of “real” news and information. As an agency team at pharmaphorum connect, we work with global pharma companies to apply this expertise in publishing, journalism and content-development to deliver research-based, content-driven and socially-amplified customer engagement.

Learn more

About PharmaVOICE

PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Learn more

Pricing

EUR 1.599,-

Delegates

  • 2 Day Conference
  • Online Documentation
  • Luncheon and Refreshments

EUR 1.799,-

Service Providers and Consultancy Companies

  • 2 Day Conference
  • Online Documentation
  • Luncheon and Refreshments

EUR 695,-

Online Documentation

  • Speaker Presentations
  • Event Materials
  • Delegates and Speaker List

Hurry Up! Only seats left

Register Now

Call for Papers

For Speaking or Sponsorship opportunities please contact John Isaac at johni@bisgrp.com or +420 27 000 3479

Submit Request